CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor With Upper Urinary Tract Carcinoma Who Underwent Radical Nephroureterectomy and Adjuvant Chemotherapy
Jee Hwan Yoon, Chang Wook Jeong, Cheol Kwak, Hyeon Hoe Kim, Ja Hyeon Ku, Ji Hyeong Yu, Hyeong Dong Yuk
Korean J Urol Oncol. 2022;20(1):34-42.   Published online 2022 February 24    DOI: https://doi.org/10.22465/kjuo.2022.20.1.34

Excel Download

De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor With Upper Urinary Tract Carcinoma Who Underwent Radical Nephroureterectomy and Adjuvant Chemotherapy
The Korean Journal of Urological Oncology. 2022;20(1):34-42   Crossref logo
Link1 Link2 Link3

De Ritis (aspartate transaminase/alanine transaminase) ratio as a significant predictor of recurrence-free survival in patients with upper urinary tract urothelial carcinoma following nephroureterectomy
Urologic Oncology: Seminars and Original Investigations. 2016;34(9):417.e9-417.e15   Crossref logo
Link1 Link2

De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase) as a Significant Prognostic Factor in Patients Undergoing Radical Cystectomy with Bladder Urothelial Carcinoma: A Propensity Score-Matched Study
Disease Markers. 2019;2019:1-8   Crossref logo
Link1 Link2 Link3

De Ritis ratio (aspartate transaminase/alanine transaminase ratio) as a significant prognostic factor after surgical treatment in patients with clear-cell localized renal cell carcinoma: a propensity score-matched study
BJU International. 2016;119(2):261-267   Crossref logo
Link1 Link2 Link3

Prognostic Role of Pretreatment De Ritis Ratio (Aspartate Transaminase/Alanine Transaminase Ratio) in Urological Cancers: A Systematic Review and Meta-Analysis
Frontiers in Oncology. 2020;10:   Crossref logo
Link1

Aspartate transaminase/alanine transaminase ratio as a significant prognostic factor in patients with sepsis: a retrospective analysis
. 2020;   Crossref logo
Link1 Link2

<p>Prognostic value of aspartate transaminase to alanine transaminase (De Ritis) ratio in solid tumors: a pooled analysis of 9,400 patients</p>
OncoTargets and Therapy. 2019;Volume 12:5201-5213   Crossref logo
Link1 Link2

Aspartate transaminase/alanine transaminase (De Ritis ratio) predicts survival in major burn patients
Burns. 2021;   Crossref logo
Link1 Link2

Prognostic value of preoperative De Ritis ratio in upper tract urothelial carcinoma treated with radical nephroureterectomy
European Urology Open Science. 2020;19:e2208-e2209   Crossref logo
Link1 Link2

MP67-04 EVALUATION OF THE DE RITIS (ASPARTATE TRANSAMINASE/ALANINE TRANSAMINASE) RATIO AS A PREDICTOR OF ONCOLOGICAL OUTCOMES IN PATIENTS WITH UPPER URINARY TRACT UROTHELIAL CARCINOMA AFTER SURGERY
Journal of Urology. 2017;197(4S):   Crossref logo
Link1 Link2 Link3